Edwards Lifesciences Corporation (EW)

Edwards Lifesciences Stock Forecast

Stock Price Forecast

The 17 analysts that cover Edwards Lifesciences stock have a consensus rating of "Buy" and an average price target of $92.35, which forecasts a 11.17% increase in the stock price over the next year. The lowest target is $79 and the highest is $104.

Price Target: $92.35 (+11.17%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$79	$92.35	$94	$104
Change	-4.90%	+11.17%	+13.16%	+25.20%

Analyst Ratings

The average analyst rating for Edwards Lifesciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jun '25	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25
Strong Buy	5	5	5	5	6	6
Buy	5	6	6	5	6	6
Hold	9	9	8	6	7	7
Sell	1	1	1	1	0	0
Strong Sell	0	0	0	0	0	0
Total	20	21	20	17	19	19

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Richard Newitter Truist Securities	Truist Securities	Hold Maintains $87 → $90	Hold	Maintains	$87 → $90	+8.34%	Nov 3, 2025
William Plovanic Canaccord Genuity	Canaccord Genuity	Hold Maintains $81 → $84	Hold	Maintains	$81 → $84	+1.12%	Nov 3, 2025
Matt Miksic Barclays	Barclays	Buy Maintains $95 → $99	Buy	Maintains	$95 → $99	+19.18%	Oct 31, 2025
Joanne Wuensch Citigroup	Citigroup	Strong Buy Maintains $95 → $96	Strong Buy	Maintains	$95 → $96	+15.57%	Oct 31, 2025
Robbie Marcus JP Morgan	JP Morgan	Hold Maintains $85 → $90	Hold	Maintains	$85 → $90	+8.34%	Oct 31, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

6.20B

Increased by 13.96%

from 5.44B

Revenue Next Year

6.81B

Increased by 9.81%

from 6.20B

EPS This Year

2.63

Decreased by -62.24%

from 6.97

EPS Next Year

2.93

Increased by 11.19%

from 2.63

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	4.39B	5.23B	4.46B	5.01B	5.44B	6.20B	6.81B
Revenue Growth	0.88%	19.29%	-14.69%	12.23%	8.57%	13.96%	9.81%
EPS	1.30	2.38	2.44	2.30	6.97	2.63	2.93
EPS Growth	-20.73%	83.08%	2.40%	-5.44%	202.39%	-62.24%	11.19%
Forward PE	-	-	-	-	-	31.57	28.40
No. Analysts	-	-	-	-	-	39	38

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	6.4B	7.1B
Avg	6.2B	6.8B
Low	5.8B	6.3B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	17.2%	14.9%
Avg	14.0%	9.8%
Low	6.2%	1.0%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	2.76	3.28
Avg	2.63	2.93
Low	2.28	2.60

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-60.4%	24.5%
Avg	-62.2%	11.2%
Low	-67.2%	-1.3%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.